VUTRISIRAN (vue TRI sir AN) treats nerve pain, tingling, or numbness in the hands or feet in people with transthyretin amyloidosis (ATTR). It may also be used to lower the risk of worsening disease and death caused by cardiomyopathy. It works by decreasing the buildup of a protein that causes nerve injury and thickening of the heart muscle. This decreases symptoms. It also makes it easier for your heart to pump blood to the rest of your body.


AMVUTTRA Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.